Concerns are growing among doctors in America that Ozempic and similar weight-loss drugs may be linked to suicide.
European regulators this week opened an investigation after three patients in Iceland reported suicidal thoughts or thoughts of self-harm.
And now the Food and Drug Administration (FDA) says it has received at least 60 reports of suicidal thoughts among patients taking the weight loss drug or its sister medication Wegovy.
Read more of the original article from DailyMail
